PWPS
VIR icon

Pinnacle Wealth Planning Services’s Vir Biotechnology VIR Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.9K Sell
6,957
-8
-0.1% -$76 0.01% 1062
2026
Q1 		$62.4K Buy
6,965
+107
+2% +$853 0.01% 1072
2025
Q4 		$41.4K Buy
+6,858
New +$40.8K ﹤0.01% 1330
2024
Q3 		– Sell
-11,333
Closed -$101K – 561
2024
Q2 		$101K Sell
11,333
-45
-0.4% -$432 0.01% 483
2024
Q1 		$115K Hold
11,378
– – 0.02% 476
2023
Q4 		$114K Buy
+11,378
New +$104K 0.02% 447

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pinnacle Wealth Planning Services's VIR Position: Q2 2026 in Review

Pinnacle Wealth Planning Services reduced its Vir Biotechnology (VIR) stake by 0.11% in Q2 2026, selling an estimated $76 and leaving 6,957 shares worth $70.9K. The position accounts for 0.01% of the portfolio, ranked #1062.

Pinnacle Wealth Planning Services first reported a position in VIR in Q4 2023 and has held it in 6 quarters since. The position peaked at $115K in Q1 2024. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Pinnacle Wealth Planning Services held 6,957 shares of Vir Biotechnology worth $70.9K as of Q2 2026.
  • Pinnacle Wealth Planning Services sold 8 Vir Biotechnology shares in Q2 2026, an estimated $76.
  • Vir Biotechnology made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1062 holding.
  • Pinnacle Wealth Planning Services first reported a position in Vir Biotechnology in Q4 2023 and has held it in 6 quarters since.
  • Pinnacle Wealth Planning Services's Vir Biotechnology position peaked at $115K in Q1 2024.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.